======= PRR5 ======= == Gene Information == * **Official Symbol**: PRR5 * **Official Name**: proline rich 5 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=55615|55615]] * **UniProt**: [[https://www.uniprot.org/uniprot/P85299|P85299]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PRR5&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PRR5|Open PubMed]] * **OMIM**: [[https://omim.org/entry/609406|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a protein with a proline-rich domain. This gene is located in a region of chromosome 22 reported to contain a tumor suppressor gene that may be involved in breast and colorectal tumorigenesis. The protein is a component of the mammalian target of rapamycin complex 2 (mTORC2), and it regulates platelet-derived growth factor (PDGF) receptor beta expression and PDGF signaling to Akt and S6K1. Alternative splicing and the use of alternative promoters results in transcripts encoding different isoforms. Read-through transcripts from this gene into the downstream Rho GTPase activating protein 8 (ARHGAP8) gene also exist, which led to the original description of PRR5 and ARHGAP8 being a single gene. [provided by RefSeq, Nov 2010]. * **UniProt Summary**: N/A |HbrB| |TORC2 signaling| |TORC2 complex| |TOR signaling| |activation of protein kinase B activity| |positive regulation of phosphatidylinositol 3-kinase signaling| |regulation of phosphatidylinositol 3-kinase signaling| |activation of protein kinase activity| |positive regulation of protein kinase activity| |positive regulation of kinase activity| |positive regulation of transferase activity| |regulation of protein kinase activity| |regulation of kinase activity| |regulation of transferase activity| |positive regulation of protein phosphorylation| |positive regulation of intracellular signal transduction| |positive regulation of phosphorylation| |positive regulation of phosphate metabolic process| |positive regulation of phosphorus metabolic process| |positive regulation of protein modification process| |cell cycle| |positive regulation of catalytic activity| |regulation of protein phosphorylation| |regulation of phosphorylation| |positive regulation of cellular protein metabolic process| |positive regulation of signal transduction| |intracellular signal transduction| |positive regulation of protein metabolic process| |positive regulation of molecular function| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |positive regulation of cell communication| |positive regulation of signaling| |regulation of intracellular signal transduction| |regulation of protein modification process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp452|Azithromycin 100μM R08 exp452]]|-1.88| |[[:results:exp510|Nicotine 3000μM R08 exp510]]|-1.81| |[[:results:exp429|Rapamycin 0.001μM R08 exp429]]|-1.7| |[[:results:exp2|5-Fluorouracil 20μM R00 exp2]]|1.77| |[[:results:exp477|DKK1 89ng/ml R08 exp477]]|2.1| |[[:results:exp517|Quercetin 20μM R08 exp517]]|2.16| |[[:results:exp471|Cholesterol 0.003 to 0.006 to 0.1μM on day2 then day6 R08 exp471]]|2.23| ^Gene^Correlation^ |[[:human genes:h:hars|HARS]]|0.572| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 15924 * **Expression level (log2 read counts)**: 4.15 {{:chemogenomics:nalm6 dist.png?nolink |}}